Bradykinin B1 Receptor Antagonists

Preferred Label : Bradykinin B1 Receptor Antagonists;

MeSH definition : Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ B1 RECEPTORS.;

MeSH synonym : Bradykinin B1 Receptor Blockers; Bradykinin B1 Receptor Inhibitors; Bradykinin B1 Antagonists; Antagonists, Bradykinin B1;

CISMeF synonym : B1 Antagonists, Bradykinin;

Is substance : O;

Détails

Origin ID

D065169;

UMLS CUI

C3850093;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
MeSH Descriptor(s) used for indexing
- receptor, bradykinin b1 [MeSH Descriptor]
Record concept(s)
- Bradykinin B1 Receptor Antagonists [MeSH concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 2-((3-(1,3-benzodioxol-5-yl)-3-(((6-methoxy-2-naphthyl)sulfonyl)amino)propanoyl)amino)-3-(4-((2,6-dimethylpiperidinyl)methyl)phenyl)-N-isopropyl-N-methylpropanamide [MeSH Supplementary Concept]
- 2-(3-oxo-1-(toluene-4-sulfonyl)-1,2,3,4-4H-quinoxalin-2-yl)-N-phenyl-acetamide [MeSH Supplementary Concept]
- 3-(4-fluorophenyl)-N-(7-(piperidin-1-ylmethyl)chroman-4-yl)-3-(3-(trifluoromethyl)phenylsulfonamido)propanamide [MeSH Supplementary Concept]
- 4-bromo-5-((2-chlorobenzoyl)amino)-1-phenyl-N-(2-(1-(4-pyridinyl)-4-piperidinyl)ethyl)-1H-pyrazole-3-carboxamide [MeSH Supplementary Concept]
- N-(2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)ethyl)-2-(1-(2-naphthylsulfonyl)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl)acetamide [MeSH Supplementary Concept]
- N-(2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)ethyl)-2-(3-oxo-1-(1,2,3,4-tetrahydroquinolin-8-ylsulfonyl)piperazin-2-yl)acetamide [MeSH Supplementary Concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients